Загрузка...
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer
PURPOSE: We evaluated whether adding bevacizumab to current platinum-based chemotherapy could improve clinical outcomes without affecting safety. MATERIALS AND METHODS: We retrospectively reviewed medical records of patients with pathologically confirmed ovarian cancer who received neoadjuvant chemo...
Сохранить в:
| Опубликовано в: : | Yonsei Med J |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Yonsei University College of Medicine
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7105404/ https://ncbi.nlm.nih.gov/pubmed/32233170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2020.61.4.284 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|